BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32356150)

  • 1. Role of VHL-JAK-STAT signaling pathway in central nervous system hemangioblastoma associated with von Hippel-Lindau disease.
    Kanno H; Yoshizumi T; Shinonaga M; Kubo A; Murata H; Yao M
    J Neurooncol; 2020 May; 148(1):29-38. PubMed ID: 32356150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmentally Arrested Basket/Stellate Cells in Postnatal Human Brain as Potential Tumor Cells of Origin for Cerebellar Hemangioblastoma in von Hippel-Lindau Patients.
    Shively SB; Edwards NA; MacDonald TJ; Johnson KR; Diaz-Rodriguez NM; Merrill MJ; Vortmeyer AO
    J Neuropathol Exp Neurol; 2022 Oct; 81(11):885-899. PubMed ID: 35980299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
    Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
    Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
    Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
    BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease.
    Vortmeyer AO; Gnarra JR; Emmert-Buck MR; Katz D; Linehan WM; Oldfield EH; Zhuang Z
    Hum Pathol; 1997 May; 28(5):540-3. PubMed ID: 9158701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the von Hippel-Lindau Gene in Hemangioblasts Causes Hemangioblastoma-like Lesions in Murine Retina.
    Wang H; Shepard MJ; Zhang C; Dong L; Walker D; Guedez L; Park S; Wang Y; Chen S; Pang Y; Zhang Q; Gao C; Wong WT; Wiley H; Pacak K; Chew EY; Zhuang Z; Chan CC
    Cancer Res; 2018 Mar; 78(5):1266-1274. PubMed ID: 29301791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemangioblastoma of the Peripheral Nervous System: A Critical Analysis of Its Rarity in Von Hippel-Lindau Disease.
    Murthy NK; Lonser RR; Spinner RJ
    World Neurosurg; 2021 Oct; 154():e707-e709. PubMed ID: 34343683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms.
    Vortmeyer AO; Falke EA; Gläsker S; Li J; Oldfield EH
    Acta Neuropathol; 2013 Mar; 125(3):333-50. PubMed ID: 23400300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The VHL tumor suppressor protein regulates tumorigenicity of U87-derived glioma stem-like cells by inhibiting the JAK/STAT signaling pathway.
    Kanno H; Sato H; Yokoyama TA; Yoshizumi T; Yamada S
    Int J Oncol; 2013 Mar; 42(3):881-6. PubMed ID: 23338840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case of von Hippel-Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas.
    Heo SJ; Lee CK; Hahn KY; Kim G; Hur H; Choi SH; Han KS; Cho A; Jung M
    Cancer Res Treat; 2016 Jan; 48(1):409-14. PubMed ID: 25715769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
    Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
    Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The occurrence of cerebellar hemangioblastoma in numerous first degree relatives with von Hippel-Lindau disease.
    Wysocka B; Wełnicka-Jaśkiewicz M; Matuszewska K; Słoniewski P; Jassem J; Izycka-Swieszewska E; Borowska-Lehman J; Limon J
    Folia Neuropathol; 1999; 37(3):175-8. PubMed ID: 10581854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel-Lindau disease.
    Vortmeyer AO; Frank S; Jeong SY; Yuan K; Ikejiri B; Lee YS; Bhowmick D; Lonser RR; Smith R; Rodgers G; Oldfield EH; Zhuang Z
    Cancer Res; 2003 Nov; 63(21):7051-5. PubMed ID: 14612494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells.
    Park DM; Zhuang Z; Chen L; Szerlip N; Maric I; Li J; Sohn T; Kim SH; Lubensky IA; Vortmeyer AO; Rodgers GP; Oldfield EH; Lonser RR
    PLoS Med; 2007 Feb; 4(2):e60. PubMed ID: 17298169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
    Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL
    Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
    Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
    BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of VHL tumourigenesis in nerve root tissue.
    Vortmeyer AO; Tran MG; Zeng W; Gläsker S; Riley C; Tsokos M; Ikejiri B; Merrill MJ; Raffeld M; Zhuang Z; Lonser RR; Maxwell PH; Oldfield EH
    J Pathol; 2006 Nov; 210(3):374-82. PubMed ID: 16981244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease.
    Cuesta AM; Albiñana V; Gallardo-Vara E; Recio-Poveda L; de Rojas-P I; de Las Heras KVG; Aguirre DT; Botella LM
    Sci Rep; 2019 Jul; 9(1):10062. PubMed ID: 31296894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients.
    Albiñana V; Villar Gómez de Las Heras K; Serrano-Heras G; Segura T; Perona-Moratalla AB; Mota-Pérez M; de Campos JM; Botella LM
    Orphanet J Rare Dis; 2015 Sep; 10():118. PubMed ID: 26394686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmentally arrested structures preceding cerebellar tumors in von Hippel-Lindau disease.
    Shively SB; Falke EA; Li J; Tran MG; Thompson ER; Maxwell PH; Roessler E; Oldfield EH; Lonser RR; Vortmeyer AO
    Mod Pathol; 2011 Aug; 24(8):1023-30. PubMed ID: 21499240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.